• CAS
  • |
  • C&EN
  • |
  • Journals
  • |
  • ACS

search site
Advanced Search »
  • Home
  • |
  • About CAS
    • CAS Media Library
    • CAS Quotes
    • Colors of Chemistry
    • 100th Anniversary Celebration
    • Careers at CAS
    • FAQs
    • Directions to CAS
    • Contact Us
  • |
  • Our Expertise
    • CAS Databases
    • Value Added Tools
    • Technical Service and Support
  • |
  • Solutions
    • Researchers
    • IP Professionals
    • Information Professionals
    • Academics
  • |
  • Products & Services
    • SciFinder
    • STN Family of Products
    • Science IP
    • CAS Client Services
    • CAS Document Detective Service
    • CD Products
    • Print Products
  • |
  • Support & Training
    • SciFinder
    • SciFinder Scholar
    • STN
    • STN Express
    • STN AnaVist
    • STN Viewer
    • STN on the Web
    • STN Easy
    • CAS Customer Care
  • |
  • News & Events
    • What's New
    • Press Room
    • News Releases
    • In the News
    • Trade Shows
  • CAS Science Spotlight Home
  • Most Requested Patent Families 2Q05-Chemistry and Related
  • About
  • What's New
Home   •   Spotlight  •  rlist2q05p  •  Most Requested Patent Families 2Q05-Chemistry and Related (6)
Most Requested Patent Families 2Q05-Chemistry and Related
spotlightlogo.gif

Following is one of the patent documents most requested by researchers using CAS electronic products.



CAS indexed 53 chemical substances from this document.
CAS subject entries for this document include: 5-HT agonists; Muscarinic receptors; Mental disorder; and 11 additional concepts.

CAPLUS COPYRIGHT 2005 ACS on STN

TITLE: Use of N-desmethylclozapine to treat human neuropsychiatric disease
INVENTOR(S): Weiner, David M.; Brann, Mark R.
PATENT ASSIGNEE(S): Acadia Pharmaceuticals Inc, USA
SOURCE: PCT Int. Appl., 27 pp. CODEN: PIXXD2
LANGUAGE: English
PATENT INFORMATION:
PATENT NO.          KIND   DATE        APPLICATION NO.        DATE
---------------     ----   --------    --------------------   --------
WO 2004064753 A2 20040805 WO 2004-US1509 20040121 WO 2004064753 A3 20041125 W: AE, AE, AG, AL, AL, AM, AM, AM, AT, AT, AU, AZ, AZ, BA, BB, BG, BG, BR, BR, BW, BY, BY, BZ, BZ, CA, CH, CN, CN, CO, CO, CR, CR, CU, CU, CZ, CZ, DE, DE, DK, DK, DM, DZ, EC, EC, EE, EE, EG, ES, ES, FI, FI, GB, GD, GE, GE, GH, GM, HR, HR, HU, HU, ID, IL, IN, IS, JP, JP, KE, KE, KG, KG, KP, KP, KP, KR, KR, KZ, KZ, KZ, LC, LK, LR, LS, LS, LT, LU, LV, MA, MD, MD, MG, MK, MN, MW, MX, MX, MZ, MZ, NA, NI

ABSTRACT:
Disclosed herein is a method to treat neuropsychiatric diseases including psychosis, affective disorders, dementia, neuropathic pain, and glaucoma. Treatment is carried out by administering a therapeutically effective amt. of N-desmethylclozapine to a patient suffering from a neuropsychiatric disease.

 

Updated 5/8/2007 12:24:33 PM
Home  |  About CAS  |  Our Expertise  |  Solutions  |  Products & Services  |  Support  |  News & Events
Copyright © 2008 American Chemical Society